Quality volume histograms of the five patients for planning phase I. (DOCX 116 kb
SUVmax variables according to pCR breast and pCR axilla and their prognostic value in triple-negativ...
Table S1. Spearmanâs rank self-correlation matrix of clinical and dosimetric variables. (XLS 26 kb
Figure S1. Scatter plots of IVIM-DWI parameters versus Age and BMI. Figure S2. Scatter plots of DCE-...
images of individual dose volume histograms and dose distributions of patients. (DOCX 15022 kb
Table S1. Spearman’s Rho values between DCE-MRI/IVIM-DWI at baseline and anthropometric variables at...
Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous cell car...
Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...
Figure. S1. Figure showing the isodose line of 20âGy (outlined in yellow) and 5âGy (outlined in ...
Tables S2aâ+âb. 1. FLAME protocol / 2. Pinkawa protocol. Dose characteristics after IMRT plannin...
PURPOSE: Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous...
Table S1. The comparison of the 3D globe, and organ-specific GP (%) calculated with local dose norma...
Figure S2. Survival outcomes according to the SUVmean change. Progression-free survival (A) and over...
Table S1. Quantitative parameters on the pre-treatment PET1 scan and inter-fractional PET2 scan. (DO...
One patient in the CRT[−] group with polypoid esophageal cancer and unexpectedly high fluorodeoxyglu...
Figure S3. Intracranial control probability according to RPA classification separated for patients t...
SUVmax variables according to pCR breast and pCR axilla and their prognostic value in triple-negativ...
Table S1. Spearmanâs rank self-correlation matrix of clinical and dosimetric variables. (XLS 26 kb
Figure S1. Scatter plots of IVIM-DWI parameters versus Age and BMI. Figure S2. Scatter plots of DCE-...
images of individual dose volume histograms and dose distributions of patients. (DOCX 15022 kb
Table S1. Spearman’s Rho values between DCE-MRI/IVIM-DWI at baseline and anthropometric variables at...
Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous cell car...
Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...
Figure. S1. Figure showing the isodose line of 20âGy (outlined in yellow) and 5âGy (outlined in ...
Tables S2aâ+âb. 1. FLAME protocol / 2. Pinkawa protocol. Dose characteristics after IMRT plannin...
PURPOSE: Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous...
Table S1. The comparison of the 3D globe, and organ-specific GP (%) calculated with local dose norma...
Figure S2. Survival outcomes according to the SUVmean change. Progression-free survival (A) and over...
Table S1. Quantitative parameters on the pre-treatment PET1 scan and inter-fractional PET2 scan. (DO...
One patient in the CRT[−] group with polypoid esophageal cancer and unexpectedly high fluorodeoxyglu...
Figure S3. Intracranial control probability according to RPA classification separated for patients t...
SUVmax variables according to pCR breast and pCR axilla and their prognostic value in triple-negativ...
Table S1. Spearmanâs rank self-correlation matrix of clinical and dosimetric variables. (XLS 26 kb
Figure S1. Scatter plots of IVIM-DWI parameters versus Age and BMI. Figure S2. Scatter plots of DCE-...